Oncology & Cancer

Cancer cells deactivate their 'Velcro' to go on the attack

Cancer cells remain clumped together via a sort of 'Velcro' which allows them to adhere to each other wherever they appear. In order for cancer cells to leave a tumour and spread throughout the body during metastatic processes, ...

Medical research

Immunotherapy reduces lung and liver fibrosis in mice

Chronic diseases often lead to fibrosis, a condition in which organ tissue suffers from excessive scarring. Researchers at the University of Zurich have now developed an immunotherapy that specifically targets the cause—activated ...

Medical research

New insights into the function of the main class of drug targets

About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors. In collaboration with researchers from the Paul Scherrer ...

Oncology & Cancer

New approach attacks 'undruggable' cancers from the outside in

Cancer researchers have made great strides in developing targeted therapies that treat the specific genetic mutations underlying a patient's cancer. However, many of the most common cancer-causing genes are so central to ...

Oncology & Cancer

Savior of T-cells may be enemy of liver immune cells

Researchers at Houston Methodist demonstrated that a surface protein called OX40, responsible for keeping one type of immune system cell alive, can trigger the death of liver immune cells, in turn starting a chain reaction ...

Diseases, Conditions, Syndromes

Effective vaccination against borreliosis possible

"Borreliosis" or "Lyme disease" is caused by the bacterium "Borrelia burgdorferi". In Austria approximately 16,000 people fall ill with borreliosis annually following a tick bite. Roughly every fifth tick in Austria carries ...

page 12 from 21